Authors
Latest:
Cell and gene therapy success: Overcoming patient and provider apprehensionThe benefits of establishing an in-depth go-to-market commercialization strategy for a new CGT in the beginning of clinical trials
Latest:
How 3PLs Can Up Their Pharma GameThe growing complexity and demand in distribution amid the pandemic present unique technology opportunities for third-party logistics providers
Latest:
COVID-19 Vaccine Distribution SystemDelivering COVID-19 vaccines to 7.8 billion people was a daunting challenge that stretched supply chains past their limits. This white paper dives into vaccine distribution plans and what vaccine manufacturers, distributors and administrators can take away from this monumental time in both the industry and history. Learn how temperature indicators and monitoring solutions played an essential role in the administration of the COVID-19 vaccine.
Latest:
Harnessing the Potential of Data to Deliver the Future of HealthcareFaster approvals, more accurate and timely medicines monitoring—all enabled by harmonized, consistent and reliable data—will drive improved patient outcomes.
Latest:
Walmart Expanding Their Efforts to Care for HIV CommunityWalmart has opened 70 Specialty Pharmacies of the Community locations across the U.S. in June, and is expected to open 80 more in 11 states by the end of the year.
Latest:
Key Considerations for Onboarding and Implementing DSCSA Services With Your 3PL Partner With Speed and ComplianceStarting May 27, 2025, the FDA’s DSCSA enforcement will require all supply chain stakeholders to implement and test serialization and tracking processes to meet compliance.
Latest:
Harnessing Digital at the Point of CareTaking advantage of new advances in tech-driven engagement to boost patient support and adherence
Latest:
Are ADMs a Viable Option for Pharma?The key questions and considerations for drug manufacturers pursuing an effective alternative distribution model.
Latest:
Postponement: A Vital Supply StrategyDrugmakers can turn to postponement, or late-stage customization, to help adapt approaches along the supply chain
Latest:
2023 challenges of the Drug Supply Chain Security Act implementation on wholesale drug distributorsExploring new guidances and future challenges for pharma trading partners in meeting looming DSCSA mandates in the US
Latest:
Navigating Abortion Restrictions Post Dobbs: Considerations for Pharmacy ProvidersAs a result of the United States Supreme Court’s overturning of Roe v. Wade and Planned Parenthood v. Casey, pharmacy providers are looking to state laws and other recently issued federal guidance in determining how they can compliantly meet patient needs and deliver medications.
Latest:
FDA Issues Guidance on Biosimilar LabelingThe draft guidance document discusses the development of labeling for proposed biosimilars and interchangeable biosimilars for submission under section 351(k) of the Public Health Service Act.
Latest:
Transforming the Patient Hub into a Hub of Patient CentricityMethods that pharma companies can use to make the hub more personalized and experiential.
Latest:
The Role and Recruitment of the Chief Patient OfficerNew C-Suite position emerges for more emphasis on patient centricity
Latest:
Ten23 Expands Sterile Manufacturing Capacity at VIVA 1 FacilityFurther expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
Latest:
Insights on Insight GatheringUnderstanding markets, influencers, and patients through better stakeholder engagement and faster analysis
Latest:
Beyond the Finish Line: Why Post-Approval Regulatory Strategy MattersIt’s essential for commercial success, but presents its share of obstacles.
Latest:
Getting Unstuck on the Path to Digital TransformationThe transition to AI and machine learning was well underway long before ChatGPT burst onto the marketplace; however, organizations were, and still are, constrained by data challenges.
Latest:
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic WasteAdvances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.
Latest:
The Role of CDMOs in the Pharma Cold Chain MachineExploring the importance of contract development and manufacturing organizations in advancing the latest technology for effective delivery of temperature-sensitive medicines.
Latest:
Popping the Gross-to-Net Bubble, Part IV: Extreme Examples of Who Grew the BubbleAn exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers played their part.
Latest:
Reimbursement-Related Analytics and ReportingAn overview of a structural approach that guides development of the analytics and related reporting that may assist brands in gaining or maintaining reimbursement positions and maximizing sales.
Latest:
Transforming Specialty Pharmacy EngagementA report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.
Latest:
Sonicu serves scores of hospital-based, specialty and retail pharmacies with our simple and affordable temperature and environmental monitoringLearn how easy and affordable it can be to adopt a wireless remote temperature and environmental monitoring system that can protect your vital temperature-sensitive assets while automating tedious compliance
Latest:
Patient Assistance Programs Pharmacy OptionsChoosing the right pharmacy to administer the program involves a number of factors.
Latest:
In New Year, Resolve to Solve Drug Supply Chain Security Act ComplianceUnder the DSCSA law, wholesale distributors, re-packagers, dispensers, and other third-party logistics providers must implement interoperable and electronic tracing of prescription products at the package level.
Latest:
Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy LaunchesHow emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.
